Almac Clinical Technologies Named “Best Clinical Trial Technology Solution Provider” in 2026 MedTech Breakthrough Awards Programme

Almac Clinical Technologies announced that it has been selected as winner of the “Best Clinical Trial Technology Solution Provider” award in the 10^th annual MedTech Breakthrough Awards programme conducted by MedTech Breakthrough, an independent market intelligence organisation that recognises the most innovative companies, technologies and products in the global digital health and medical technology market. 

“Our years of Clinical Trial Technology delivery and support experience have informed every component of the platform – from user experience to compliance safeguards. Almac Trial Coordinator is reliable in environments where precision, auditability, and regulatory alignment matter most. We are delighted to be recognised by MedTech Breakthrough for the impact Almac Trial Coordinator will continue to have on crucial studies and the patients that rely on them,” said Valarie Higgins, President and Managing Director of Almac Clinical Technologies. 

“Combining interoperability, automation, and user-centred design, Almac Trial Coordinator sets a new benchmark for how modern trials should be managed. The disconnect across individual technologies like eCOA, IRT, and more forces sites and study teams to rely on manual workarounds, duplicated data entry, and error-prone processes, slowing down studies, burdening sites, and complicating operational oversight,” said Steve Johansson, managing director, MedTech Breakthrough. “Almac Clinical Technologies delivers something genuinely transformative: a unified operational command centre designed to simplify, streamline, and elevate the clinical trial experience for all stakeholders. We’re pleased to award Almac Group with ‘Best Clinical Trial Technology Solution Provider!’”